Motus Gi Holdings Inc's Competitiveness
A competitive positioning analysis and financial ratio benchmarking of Motus Gi Holdings Inc (MOTS) against its publicly traded competitors: sales growth, net income, profitability, valuation and market share, plus each peer's market capitalization, revenue, income and employees. Free below: the top 5 peers. Subscriber access adds the full competitor list and CSV downloads.
Key Findings: Motus Gi Holdings Inc vs Its Competitors
- TTM: Trailing 12-month revenue of 0M vs 95,065M combined for its competitors (0.0% combined share).
- Trending: Latest-quarter revenue run-rate is decelerating (-21.7% annualized vs trailing 12 months), vs decelerating (-11.1%) for its tracked peer group.
- Growth: Motus Gi Holdings Inc generated 14.3% revenue growth year over year in Q1 2024, vs 3.9% for its competitors combined.
- Profitability: Its -11,907.8% net margin compares with 7.9% for the peer group.
- Peer revenue share: Motus Gi Holdings Inc accounted for 0.0% of combined revenue among its tracked peer group, up from 0.0% a year earlier.
- Peer differentiation: Revenue per employee of $0.01M compares with $0.35M for the peer group (0.0x).
Every figure above is sourced and cited in detail further down this page (Market Structure, Profitability & Cost Structure, Productivity vs Peers).
MOTS Sales vs. its Competitors, Q1 2024
Motus Gi Holdings Inc reported revenue growth of 14.29 % year on year in Q1 2024, above its competitors' combined revenue growth of 3.92 %.
With a net margin of -11,907.81 %, Motus Gi Holdings Inc reported lower profitability than its competitors (7.93 %).
Motus Gi Holdings Inc generated 0.00 % of the combined sales of its peer group, up from 0.00 % a year earlier.
API endpoints for this dataset
Motus Gi Holdings Inc vs. its Competitors, Q1 2024
Revenue growth, year on year
Net margin
Revenue run-rate vs trailing 12 months
TTM net margin
TTM = trailing twelve months. Run-rate annualizes the latest quarter (×4) and compares it to TTM. In millions of $. High-Confidence Competitors are named as a competitor directly in Motus Gi Holdings Inc reports; Similar-Size Competitors are the closest peers by market-cap rank within the same industry; Similar Growth & Profitability Competitors are the closest peers by combined revenue growth, operating margin and ROIC, all independent of the competitor list.
TTM revenue, latest-quarter run-rate and net income/margin benchmarked across Motus Gi Holdings Inc and its 4 competitor groupings. Available under Commercial License.
| Entity | TTM Revenue | Rev Run-rate vs TTM |
|---|---|---|
| Motus Gi Holdings Inc | $12,345M | +12.3% · Accelerating |
| Competitors combined | $12,345M | +12.3% · Accelerating |
| High-Confidence Competitors (4) | $12,345M | +12.3% · Accelerating |
TTM revenue, run-rate and net margin benchmarking across Motus Gi Holdings Inc's competitor groups requires a Commercial License.
For context: the Medical Equipment & Supplies industry grew revenue 14.4% year over year, combined, vs 14.3% for Motus Gi Holdings Inc. Motus Gi Holdings Inc's share of combined industry revenue moved from 0.00% to 0.00%, a gain of 0.00 percentage points.
Motus Gi Holdings Inc's Competitor Quality Breadth
Group definitions: see Methodology: Performance Group Definitions.
| Entity | Profitable | Expanding | Above Industry Growth | Distressed |
|---|---|---|---|---|
| Motus Gi Holdings Inc | - | No | No | Yes |
| Competitors combined (32) | ||||
| High-Confidence Competitors (5) |
Source: CSIMarket API, trailing 12 months. Altman Z-Score is not shown here: it is not populated in the underlying data for any company. Percentages are of companies in each group that report the relevant metric, not of the full group size.
MOTS Stock Performance relative to its Competitors
MOTS Stock Performance relative to High-Confidence Competitors
5 Best-Performing Tracked Competitors, Trailing 12 Months
| # | Competitor | TTM Share Price Return | vs U.S.A. 500 |
|---|---|---|---|
| 1 | Pulse Biosciences Inc | 282.9% | Outperformed |
| 2 | Exact Sciences Corporation | 282.9% | Outperformed |
| 3 | Becton Dickinson And Company | 282.9% | Outperformed |
| 4 | Orasure Technologies Inc | 282.9% | Outperformed |
| 5 | Profound Medical Corp | 282.9% | Outperformed |
TTM share price return and U.S.A. 500 outperformance for Motus Gi Holdings Inc's best-performing competitors requires a Commercial License.
Source: CSIMarket API, trailing 12 months.
Motus Gi Holdings Inc's Comment on Competition and Industry Peers
Publicly Traded Peers of Motus Gi Holdings Inc
Revenue and income for trailing 12 months, in millions of $, except employees| Company | Market Cap | Revenues |
|---|---|---|
 Motus Gi Holdings Inc |
0.00 | 0.33 |
 Medtronic Plc |
132,095.43 | 37,542.00 |
 Boston Scientific Corporation |
63,917.04 | 21,070.00 |
 Becton Dickinson And Company |
59,227.76 | 20,840.00 |
 Steris Plc |
25,359.98 | 5,935.90 |
 Exact Sciences Corporation |
19,599.02 | 3,245.31 |
| SUBTOTAL | 326,894.37 | 99,580.50 |
Sign in to see all competitors of Motus Gi Holdings Inc .
Sources: see Methodology: Peer & Competitor Identification, Sourcing.
Updated on:
Focus of this report: publicly traded companies. Ten additional tables on Motus Gi Holdings Inc versus competitors, including market share analysis, are in the navigation menu under Competition. To download the tables, please subscribe.
Motus Gi Holdings Inc's Competitors Named by the Company
Competitive relationships identified from Motus Gi Holdings Inc reports and corroborating sources, each with a basis and confidence.| Competitor | Basis | Confidence |
|---|---|---|
| Conmed Corporation | Company report | 85% |
| Medtronic | Company report | 85% |
| Boston Scientific | Company report | 85% |
| Steris | Company report | 85% |
| Medjet Ltd. | Company report | 85% |
| Ambu A/S | Company report | 85% |
| Fujifilm Medical | Company report | 85% |
| Pentax Medical | Company report | 85% |
| Medivators | Company report | 85% |
| Erbe | Company report | 85% |
| Olympus Corp | Company report | 85% |
| Cantel Medical | Company report | 85% |
| Exact Sciences Corporation | Company report | 85% |
| Steris Plc | Company report | 85% |
| Hologic Inc | Company report | 85% |
| Escalon Medical Corp | Company report | 85% |
| Lensar Inc | Company report | 85% |
| Imaging Diagnostic Systems Inc | Company report | 85% |
| Guided Therapeutics Inc | Company report | 85% |
| Orasure Technologies Inc | Company report | 85% |
| Becton Dickinson And Company | Company report | 85% |
| Iridex Corp | Company report | 85% |
Company report basis, confidence, active dates and source counts for Motus Gi Holdings Inc's named competitors require a Commercial License.
Methodology: see Methodology: Peer & Competitor Identification, Sourcing.
Motus Gi Holdings Inc's Business Segment Mix vs Peers
Revenue by operating segment or division, as named and reported by each company. Segment names are the filer's own and are not standardized across companies. Do not assume a same-named or similarly-named segment is defined identically between two companies. Shares are of each company's own total revenue and are not required to sum to 100% (intersegment revenue, unallocated items).| Company | Largest Segment |
|---|---|
| Medtronic Plc | CARDIOVASCULAR 38.34 % |
| Boston Scientific Corporation | Cardiovascular 66.29 % |
| Becton Dickinson And Company | Medical Essentials 34.94 % |
| Hologic Inc | Diagnostics 51.18 % |
| Pulse Biosciences Inc | Single Reportable Segment 100.00 % |
Source: operating segment revenue as reported in each company's reports (10-K/10-Q), via the CSIMarket API, leaf-level reportable segments only (parent roll-up segments are excluded where sub-segments are separately disclosed).
Sign in to see all peers for Motus Gi Holdings Inc .
Motus Gi Holdings Inc's Productivity vs Peers Comparison
Revenue and income per employee, trailing 12 months, in $; market cap in millions of $| Company | Market Cap | Revenue / Employee | Income / Employee |
|---|---|---|---|
| Motus Gi Holdings Inc | 0 | 10,548 | -519,419 |
| Medtronic Plc | 132,095 | 395,179 | 55,463 |
| Boston Scientific Corporation | 63,917 | 357,119 | 59,220 |
| Becton Dickinson And Company | 59,228 | 289,444 | 13,069 |
| Steris Plc | 25,360 | 326,525 | 43,187 |
| Exact Sciences Corporation | 19,599 | 450,738 | -28,882 |
| PEERS TOTAL | 326,894 | 354,965 | 36,591 |
Sign in to see all peers for Motus Gi Holdings Inc .
Motus Gi Holdings Inc's Geographic Revenue Exposure vs Peers
Revenue by country/region as reported in each company's most recent report. Disclosure granularity varies by filer (some report by country, others by broad region) and is shown as disclosed.| Company | Largest Market |
|---|---|
| Medtronic Plc | United States 49.83 % |
| Boston Scientific Corporation | United States 64.40 % |
| Becton Dickinson And Company | United States 61.88 % |
| Exact Sciences Corporation | United States 93.11 % |
| Hologic Inc | Non-US 30.23 % |
Source: revenue geography as reported in each company's reports (10-K/10-Q), via the CSIMarket API. Percentages are of that company's own total consolidated revenue for its most recent reported period.
Sign in to see all peers for Motus Gi Holdings Inc .
Motus Gi Holdings Inc's Position in Industry Market Structure
Market-capitalization share and concentration across all 218 companies in Motus Gi Holdings Inc's industry classification, broader than the peer set above. Market cap in millions of $.Motus Gi Holdings Inc ranks #0 of 218 companies by market capitalization in its industry, holding 0.00 % of total industry market cap. The industry's Herfindahl-Hirschman Index (HHI) is 607, indicating a unconcentrated market structure (see Methodology: Market Structure & Concentration).
| Rank | Company | Market Cap | Industry Share |
|---|---|---|---|
| 1 | Intuitive Surgical Inc | 164,558 | 13.47 % |
| 2 | Medtronic Plc | 132,095 | 10.81 % |
| 3 | Stryker Corp | 125,732 | 10.29 % |
| 4 | 3m Company | 98,540 | 8.06 % |
| 5 | Boston Scientific Corporation | 1,234 | 5.2% |
| 6 | Edwards Lifesciences Corporation | 1,234 | 5.2% |
| 7 | Becton Dickinson And Company | 1,234 | 5.2% |
| 8 | Alcon inc | 1,234 | 5.2% |
| 9 | Medline Inc | 1,234 | 5.2% |
| 10 | Resmed Inc | 1,234 | 5.2% |
| 0 | Motus Gi Holdings Inc | 0 | 0.00 % |
Market cap and industry share for the rest of Motus Gi Holdings Inc's industry peers requires a Commercial License.
Source: CSIMarket API (daily market-structure computation) across CSIMarket's industry classification, market capitalization as of 2026-11-06.
Motus Gi Holdings Inc's Valuation vs Competitive Position
Valuation multiples vs the Medical Equipment & Supplies industry average (342 companies, excluding loss-making/negative-equity outliers), alongside returns on capital for context on whether a premium or discount lines up with measurably stronger or weaker returns. See the full Medical Equipment & Supplies industry valuation benchmarks.| Metric | Company | Industry Average | Difference |
|---|---|---|---|
| P/E | - | 36.9x | - |
| EV / EBITDA | 1.3x | 17.8x | -16.5x |
| P/B | 11.9x | 4.6x | +7.3x |
| Return on Equity | -2,784.61 % | industry aggregate | -2,788.87 % |
| Return on Invested Capital | 135.98 % | -6.78 % (avg) | 142.76 % |
Source: CSIMarket API, trailing 12 months. A valuation premium or discount is not, by itself, a judgment of over- or under-valuation. Compare it against the return and growth context shown elsewhere on this page.
Motus Gi Holdings Inc's Multi-Year Financial Trajectory
Fiscal-year revenue growth, operating margin, return on invested capital and P/E, as reported in company reports.| Metric | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| Revenue Growth | - | -8.41 % | 298.98 % | 51.41 % | -46.11 % |
| Operating Margin | -21,902.80 % | -19,435.71 % | - | - | - |
| Return on Invested Capital | -66.08 % | -59.85 % | -47.96 % | -91.61 % | 82.32 % |
| P/E | - | - | - | - | - |
Source: CSIMarket API, fiscal-year figures. P/E is this company's own historical ratio at each fiscal year end and can swing sharply around an earnings trough: that is real, not a data error.
Motus Gi Holdings Inc's Competitive Forces (Porter's Five Forces)
Only the forces this data can support honestly are shown; the other three are marked as such rather than guessed.| Force | Assessment | Basis |
|---|---|---|
| Competitive Rivalry | High | Industry HHI of 607 (see Industry Market Structure & Concentration above) |
| Barriers to Entry | High (capital intensive) | Capital intensity (capex / revenue) of 19.88 % vs industry average 7.13 % (see Profitability & Cost Structure above) |
Note: see Methodology: Porter's Five Forces. Supplier power and buyer power are covered on Motus Gi Holdings Inc's dedicated Suppliers and Customers pages, not here.
Motus Gi Holdings Inc's SWOT
Every point below is a fixed rule applied to a metric already shown elsewhere on this page (Market Structure, Profitability, Valuation, Run-Rate, Stock Performance, Quality Breadth) not an independent strategic assessment. A blank quadrant means no rule was met, not that none apply.Strengths
No rule matched.
Weaknesses
- Return on equity 2,788.9 points below the industry aggregate.
- Latest-quarter revenue run-rate is decelerating (-21.7% annualized vs trailing 12 months).
- Piotroski F-Score of 2 or below, the standard financial-distress signal.
Opportunities
- A meaningful share of competitors (34.40 %) show financial-distress signals, a possible opening to gain share.
Threats
- Tracked peer group's revenue run-rate is broadly decelerating (-11.1% annualized).
- High capital intensity requires continuous reinvestment just to keep pace with the industry.
Methodology: see Methodology: SWOT Analysis.
Motus Gi Holdings Inc's Financial Strength vs Peers Comparison
Quick ratio, working capital, debt to equity and asset turnover, trailing 12 months| Company | Quick Ratio | Working Capital | Debt / Equity |
|---|---|---|---|
| Motus Gi Holdings Inc | 1.55 | 1.80 | 6.79 |
| Medtronic Plc | 0.15 | 2.10 | 0.57 |
| Boston Scientific Corporation | 0.23 | 1.50 | 0.46 |
| Becton Dickinson And Company | 0.10 | 1.00 | 0.73 |
| Steris Plc | 0.15 | 2.15 | 0.27 |
| Exact Sciences Corporation | 1.22 | 2.68 | 0.95 |
Sign in to see all peers for Motus Gi Holdings Inc .
Quick ratio = cash / current liabilities; working capital ratio = current assets / current liabilities; asset turnover = revenue / total assets. Peers in the Blank Checks industry are excluded.
Motus Gi Holdings Inc's Revenue and Income Growth vs Peers
Quarterly revenue and net income growth, year over year and quarter over quarter| Company | Period | Revenue Y/Y | Income Y/Y |
|---|---|---|---|
| Motus Gi Holdings Inc | Q1 2024 | +14.3 % | - |
| Medtronic Plc | Q2 2026 | +13.7 % | +41.3 % |
| Boston Scientific Corporation | Q3 2026 | +1.4 % | -23.2 % |
| Becton Dickinson And Company | Q2 2026 | +5.4 % | -34.3 % |
| Steris Plc | Q1 2026 | +7.3 % | +50.8 % |
| Exact Sciences Corporation | Q4 2025 | +23.1 % | - |
| PEERS TOTAL | +8.1 % | +39.1 % |
Sign in to see all peers for Motus Gi Holdings Inc .
Growth is shown only where both periods are positive. Peers in the Blank Checks industry are excluded.
Motus Gi Holdings Inc's Peers' Costs of Sales and Capital Expenditures
Context for revenue growth: peer costs and capex, year over year and quarter over quarter| Company | Period | Costs Y/Y | Capex Y/Y |
|---|---|---|---|
| Motus Gi Holdings Inc | Q1 2024 | +33.3 % | - |
| Medtronic Plc | Q2 2026 | +13.8 % | -0.2 % |
| Boston Scientific Corporation | Q3 2026 | +12.3 % | -0.6 % |
| Becton Dickinson And Company | Q2 2026 | +7.1 % | -12.8 % |
| Steris Plc | Q1 2026 | +6.2 % | - |
| Exact Sciences Corporation | Q4 2025 | +19.5 % | - |
Sign in to see all peers for Motus Gi Holdings Inc .
Motus Gi Holdings Inc's Returns and Turnover vs Peers
ROA, ROI and ROE (trailing 12 months), receivables and inventory turnover| Company | ROA | ROI | ROE |
|---|---|---|---|
| Motus Gi Holdings Inc | - | - | - |
| Medtronic Plc | 5.71% | 6.46% | 10.64% |
| Boston Scientific Corporation | 7.82% | 9.14% | 13.75% |
| Becton Dickinson And Company | 1.77% | 2.22% | 3.79% |
| Steris Plc | 7.53% | 7.97% | 11.29% |
| Exact Sciences Corporation | - | - | - |
Sign in to see all peers for Motus Gi Holdings Inc .
ROA = net income / total assets; ROI = net income / investments; ROE = net income / equity; turnover ratios use trailing 12 month revenue (receivables) and cost of sales (inventory).
Motus Gi Holdings Inc's Valuation vs Peers
P/E, price to sales, PEG, price to cash flow and price to book| Company | P/E | Price / Sales |
|---|---|---|
| Motus Gi Holdings Inc | - | 0.01 |
| Medtronic Plc | 302.32 | 3.52 |
| Boston Scientific Corporation | 18.68 | 3.03 |
| Becton Dickinson And Company | 65.03 | 2.84 |
| Steris Plc | 32.44 | 4.27 |
| Exact Sciences Corporation | - | 6.04 |
| PEERS AVERAGE | 31.90 | 3.28 |
Sign in to see all peers for Motus Gi Holdings Inc .
P/E = price / diluted EPS (trailing 12 months); PEG = P/E divided by EPS growth; the average row divides the peers' combined market cap by their combined income, sales, cash flow and equity.